Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.78 -1.08%
Revenue Growth %: -1.9%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
DIT, AMC, DPZ, More
Revenue Growth %: -1.9%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer temporarily discontinues premarin vaginal cream in India, citing supply challenges - Reuters
- Morgan Stanley upgrades Global Payments to Overweight on Worldpay optimism
- Prologis (PLD) Tops Q2 EPS by 38c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
